HiFiBiO Therapeutics

HiFiBiO Therapeutics is an emerging multinational biotechnology company dedicated to harnessing the human immune system to combat diseases. The company combines deep-rooted biological expertise with our comprehensive single-cell analysis technology to rapidly discover and advance a pipeline of antibody therapeutics for cancer and autoimmune diseases. Moreover, HiFiBiO Therapeutics is committed to benefiting patients through open innovation partnerships with industry and academia.